🌟 #ESTRO26 hits a new record! 🌟 4,091 abstracts submitted — over 500 more than last year! 🚀 Thank you to our incredible community! 💛Your research is what makes ESTRO the truly international hub of innovation in #radiotherapy. #ScientificExcellence #InnovationInCancerCare

Ping @maryamlustberg.bsky.social @drsgraff.bsky.social @stage4kelly.bsky.social @itsnotpink.bsky.social @coffeemommy.bsky.social @icromeattini.bsky.social @realbowtiedoc.bsky.social @barbaramelao.bsky.social @drnataliagandur.bsky.social

See you all at #ASTRO25! #MedPhys #radoncsky

🎥 New video out! Excited to share the story of the IMPORTANT Project-the mission, clinical goals & innovative approach to optimizing CDK4/6-inhibitor treatment for older patients with advanced breast cancer ▶️ Watch the video: play.mediaflow.com/ovp/17/72DFN... 🔗 Learn more: important-project.com

📌 Opting Out of Therapy for Early-Stage Breast Cancer: How Far Might We Go? ✨Prof @icromeattini.bsky.social 👉🏻 How to Integrate Radiotherapy Into Current Treatment Concepts❗️ @oncoalert.bsky.social #OncoAlertAF #ASCO25 #RadOnc

Coming up today: Medical oncology/hematology fellow Dr. Emma Schatoff's poster session on "Risk factors associated with de novo metastatic colorectal cancer in early onset colorectal cancer" TODAY at the 2025 @ascocancer.bsky.social Annual Meeting. #ASCO25. 🗓️: 5/31 from 9-12pm CT

@cliffordhudis.bsky.social at #ASCO25: ~40% cut to NCI budget in Admin's '26 proposal. We are in a tragic paradox: remarkable science & historic cuts to resources needed to turn these opps into hope for millions of pts. Our advocacy, is more important than ever ➡️ brnw.ch/21wT3U4

The OncoAlert🚨ROUND UP Now Out‼️ Covering May 15-22, 2025 REGISTER at oncoalert360.com OR oncoalert.m-pages.com/nhMpwe/oncoa... youtu.be/xgIw0BISCpo @elisaagostinetto.bsky.social @barbaramelao.bsky.social @elisaagostinetto.bsky.social @icromeattini.bsky.social @realbowtiedoc.bsky.social

The VJ OA Oncology Journal Club Dr. Evandro de Azambuja discussing APHINITY in #BreastCancer now on APPLE PODCASTS podcasts.apple.com/se/podcast/o... @elisaagostinetto.bsky.social @elisabettabonzano.bsky.social @icromeattini.bsky.social @maryamlustberg.bsky.social

Hola #medsky #cansky #radonc #bcsm NRG Oncology is here👇🏻👇🏻 Give them a follow!

Kicking Off ESTRO25: What’s Happening on Day 1 @estroradiotherapy.bsky.social @cancerphysicist.bsky.social @icromeattini.bsky.social @gerryhanna.bsky.social oncodaily.com/blog/estro25... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESTRO25 #ESTRO2025

✨We're thrilled to be taking part in #ESTRO25 in Vienna! EORTC researchers will be presenting cutting-edge findings in #RadiationOncology, a cornerstone of our scientific strategy. Find out more: www.eortc.org/blog/2025/05... @estroradiotherapy.bsky.social #CancerResearch

ESTRO25 has kicked off! And what a start - absolutely amazing keynote talk by Pascal Uffer, providing a combined patient and entrepreneur perspective on optimising cancer treatment #ESTRO25 #RadOnc

What a start , @mguckenberger.bsky.social with an emotional and inspiring talk at the opening Ceremony, Pascal Uffer delivered more than a talk ; if cancer were a start up. #ESTRO25 #radonc #radiotherapy

Thinking about your next move in #RadiationTherapy? Join us on May 15th for a free online info session and explore how our flexible, fully online postgrad programmes can help you specialise, lead, or innovate to reach your clinical and research goals. 📆 Register here: bit.ly/RadTherapy2025

Planning Automation for Treatment Techniques Comparison and Robustness Analysis: Tangential IMRT and VMAT for Whole Breast Irradiation #BreastCancer #medphys #radonc #OncoAlert @oncoalert.bsky.social Free 50-day link: www.advancesradonc.org/article/S245...

Planning Automation for Treatment Techniques Comparison and Robustness Analysis: Tangential IMRT and VMAT for Whole Breast Irradiation #BreastCancer #medphys #radonc #OncoAlert @oncoalert.bsky.social Free 50-day link: www.advancesradonc.org/article/S245...

Long-Term Outcomes of #Radiation Monotherapy Versus Combined RT + Hormone Therapy in Low-Risk Early-Stage #BreastCancer Patients 70 Years or Older After Breast-Conserving Surgery @oncoalert.bsky.social #OncoAlert @ijrobp.bsky.social #radonc www.redjournal.org/article/S036...

📢 Just published! A phase II study of #abemaciclib for patients with #retinoblastoma-positive, triple-negative #metastatic breast cancer. 🔓https://pubmed.ncbi.nlm.nih.gov/39908010/ @drtimothyerick.bsky.social @nlinmd.bsky.social @stolaney1.bsky.social

#radonc #medsky #cansky

UC San Diego Rad Med is now on BlueSky! We are excited to connect and engage with the #radonc and #medphys community!

Day Three #OncoAlertColloquium 🚨 #BreastCancer REGISTER for FREE HERE👉 buff.ly/4gsEa2f prof @icromeattini.bsky.social 🇮🇹 👏🏻 Radiation Oncology in Breast Cancer: Year in Review @oncoalert.bsky.social

Congrats to all the new Fellows of @ascocancer.bsky.social especially Drs Arjun Gupta, @ryannipp.bsky.social, and @lymphomadoc.bsky.social 🙌🙌🙌 Excited to be in your FASCO class and celebrate with you in Chicago this year. 🥳

Day3⃣ #OncoAlertColloquium 🚨 #BreastCancer REGISTER for FREE HERE👉 https://buff.ly/3Q6ttHY @Icro_Meattini 🇮🇹 Radiation Oncology in Breast Cancer: Year in Review REGISTER NOW for a Live chat with Dr. Meattini @icromeattini.bsky.social @elisaagostinetto.bsky.social @elisabettabonzano.bsky.social

United in our goals - equity of access for all our patients #WorldCancerDay #radonc #medonc #breastcancer #OncoAlert @oncoalert.bsky.social

Sot është Dita Botërore e Kancerit #WorldCancerDay ditë që na bashkon në luftën për një të ardhme më të mirë për pacientët me kancer në Shqipëri dhe kudo në botë🧡 Kjo nuk është vetëm një betejë për trajtim – është një betejë për dinjitet, për jetë dhe për një të ardhme më të drejtë për të gjithë!

CNS metastases are the main challenge in HER2+ breast cancer - Nelson Moss @mskcancercenter.bsky.social oncodaily.com/blog/nelson-... #BreastCancer #Cancer #MemorialSloanKettering #Health #OncoDaily #Oncology #Medicine

🌍 This #WorldCancerDay, we celebrate progress and innovation in the fight against cancer. Discover the groundbreaking advancements shaping oncology in 2024, from immunotherapy to personalised medicine. 💡🔬 Read more: https://buff.ly/3Ewkmha #Oncology #CancerResearch

Fixed dose of capecitabine vs standard dose for Metastatic Breast Cancer - Paolo Tarantino @ptarantinomd.bsky.social oncodaily.com/blog/236887 #BreastCancer #Cancer #MetastaticBreastCancer #Health #OncoDaily #Oncology #Medicine

The results of our translational research project on lobular breast cancer at BSMO25 - Elisa Agostinetto @elisaagostinetto.bsky.social oncodaily.com/blog/elisa-a... #BreastCancer #BSMO25 #Cancer #OncoDaily #Oncology #Medicine #Health

Higher NTCP with variable RBE predictions in Proton RT of brain tumours- especially for blindness and deppendent in Patient factors. LET or track-end optimization can lower the risk. @hzdr.bsky.social @oncoalert.bsky.social www.sciencedirect.com/science/arti...

*NEW* Review from Prof Rob Bristow's lab on the relationship between #hypoxia in tumours, genomic instability and tumour #evolution "Possible ways to counter the effects of hypoxia to block tumour evolution and improve treatment outcomes are described." @mcrcnews.bsky.social @cancerresearchuk.org

Biomarker-Directed Radiotherapy in Breast Cancer: A Narrative Review is out JAMA oncol! @jama.com A robust clinical and analytical validation of biomarkers to ensure clinical utility for RT optimization is still needed ☢️ #radonc #OncoAlert @oncoalert.bsky.social jamanetwork.com/journals/jam...

The OncoAlert Colloquium🚨NEXT WEEK FREE REGISTRATION HERE👉 buff.ly/3CChgre @drchoueiri.bsky.social @icromeattini.bsky.social @yukselurun.bsky.social @aftimosp.bsky.social @jrgralow.bsky.social @elisabettabonzano.bsky.social @elisaagostinetto.bsky.social @lymphomadoc.bsky.social

Cancer Statistics Just Out for 2025 out on American Cancer Society Journals acsjournals.onlinelibrary.wiley.com/doi/epdf/10.... #ProstateCancer has one of the highest contemporary survival rates at 97%, followed closely by testicular cancer (95%) and melanoma (94%)

Biomarker-Directed Radiotherapy in Breast Cancer: A Narrative Review is out JAMA oncol! @jama.com A robust clinical and analytical validation of biomarkers to ensure clinical utility for RT optimization is still needed ☢️ #radonc #OncoAlert @oncoalert.bsky.social jamanetwork.com/journals/jam...

Who knew 2hours could go so quickly! Great discussions from a global perspective tackling topics influencing recruitment and retention of Radiation Therapists #ProtectOurWorkforce #ESTRO #RTT Workshop

Nov 30 is the final deadline for the Adaptive special issue. Enjoying the spirit of creativity and innovation in #radonc! Exclusive tip just for #radoncsky - the next CFP by @drdavidpalma.bsky.social tentatively being focused on clinical trials in SBRT and next maybe particles. Comments welcomed.

Dear colleagues, Join us for the 5th #OncoAlert Colloquium! 🚨🌟 👉 buff.ly/3CChgre 👈 📅 February 3-9, 2025 🎟️ FREE Registration 📰one week covering the latest in oncology Don’t miss this unique #oncology event! 🌍👩‍⚕️👨‍⚕️ @oncoalert.bsky.social #OncoAlertAF

Out today! 🤩 JCO Oncology Practice Special Issue dedicated to the challenge of Financial Toxicity in Oncology. Great work by @fumikochino.bsky.social @ryannipp.bsky.social pulling this issue together.

‼️ EUROPA Stage I HR+ breast cancer in women 70+ -> lumpectomy -> APBI vs endocrine Better QoL with APBI! Very important trial! #radonc @icromeattini.bsky.social

Clinical Case Challenges on Castrate Resistant Prostate Cancer by Mirrors of Medicine (Free & CME Accredited) Link to access👉 https://buff.ly/4ipSU4o Join the Mirrors of Medicine PinPoint Case Platform, a case-based CME tool that helps apply the latest evidence to practice.

Accounting for approximately 350,000 deaths annually worldwide, cervical cancer is preventable with HPV vaccination and screening. Newer chemotherapy, radiotherapy, and immunotherapy techniques have improved survival. Learn more in a new review: nej.md/41Rw0gb #MedSky #oncology

What is the impact of drug-drug interactions between palbociclib and proton pump inhibitors in #breastcancer? 💊 Can PPI use explain why the PALLAS trial was negative? Now out in @ESMO_Open our analysis of #PALLAS exploring this question👇🏻 @oncoalert.bsky.social www.sciencedirect.com/science/arti...

🎥 @icromeattini.bsky.social‬ highlights post-surgery breast cancer treatment de-escalation strategies like partial breast irradiation & hypofractionation, reducing treatment burden: ➡️ https://buff.ly/4gQPsxT ⬅️ @sabcs.bsky.social #SABCS24 #BreastCancer

Shout out to our faculty @drsgraff.bsky.social @erikahamilton9.bsky.social @hoperugo.bsky.social @elisaagostinetto.bsky.social @elisabettabonzano.bsky.social @icromeattini.bsky.social @tmprowell.bsky.social (Honorary Faculty) @stolaney1.bsky.social @fernandoonco.bsky.social

Artifical Intelligence research presented at the @ascocancer.bsky.social 2024 annual meeting. dailynews.ascopubs.org/do/ai-empowe...

The @oncoalert.bsky.social Newsletter NOW OUT‼️ Covering December 20-26, 2024🎄 👉🏻REGISTER AT www.OncoAlert360.com OR buff.ly/48Xpgz0 📩📩📩

Also at Christmas.. the @oncoalert.bsky.social newsletter is out!!!🎄✨ Register at Oncoalert360.com to receive it in your inbox 📥

#Encorafenib + #Ceruximab + mFOLFOX is approved in 1L for BRAFV600e based off #BREAKWATER - ORR 61% vs 40% - mDoR: 13.9mos vs 11.1mos - AEs:GI tox, rash #cansky #oncsky #gism